Page URL: https://www.bionews.org.uk/page_92593

Gut stem cells may help to treat cancer

27 September 2010
Appeared in BioNews 577

Scientists from Cancer Research UK, Cambridge have suggested a new model for gut stem cell renewal.

It was thought that gut stem cells could only renew themselves via a process of hierarchical cell division - meaning that only a small population of stem cells are able to give rise to all the different types of cell which make up the gut. These cells were then thought to divide to produce daughter stem cells exhibiting a more limited capacity for transformation into cells of the gut.

This new study shows that gut stem cells are in fact capable of self-renewal through a process where neighbouring cells can divide and replace lost stem cells in a 'one in, one out' system. Therefore, only one population of gut stem cells exists with no hierarchy, and this is able to produce all the different cell types of the gut.

This was in contrast to the previous model, where only a few types of gut stem cell were able to do this via daughter precursor cells.

Dr Doug Winton, lead researcher, said: 'We've shown for the first time how the population of stem cells is maintained in the gut and essentially it is a random process with no predetermined fate for the stem cells'.

Understanding the process is important because the cells of the gut constantly undergo cell division in order to regenerate lost cells. This is made possible by the presence of stem cells which are able to react very quickly to lost cells and replace them accordingly. Problems arising during regeneration can cause uncontrolled division that may lead to bowel cancer.

Commenting on the findings, Dr Lesley Walker from Cancer Research UK said: 'This basic biology research could one day lead to real benefits for patients. Cancer stem cells are more resistant to chemotherapy and radiotherapy than the cells that make up the bulk of a tumour, so understanding more about how they behave could lead to better treatments for bowel cancer'.

These findings were published in the journal Science.

SOURCES & REFERENCES
Cell find could boost cancer fight (Press Association)
Press Association |  23 September 2010
Intestinal stem cell replacement follows a pattern of neutral drift
Science Express |  23 September 2010
Scientists reveal gut stem cell secrets
Cancer Research UK |  23 September 2010
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
10 November 2014 - by Dr Charlotte Warren-Gash 
Our genetic make-up influences the type of bacteria that live in our gut, which in turn influences how likely we are to be overweight, a twin study has found...
27 October 2014 - by Siobhan Chan 
A section of functioning human intestine has been transplanted into mice, giving scientists a new model with which to study intestinal diseases...
15 May 2012 - by Antony Blackburn-Starza 
Stem cells transplanted into the brain may offer protection against the side effects of chemotherapy, say US researchers...
12 September 2011 - by Mehmet Fidanboylu 
It is hoped that a new method for studying cell development could lead to cures for diseases such as cancer, UK scientists have reported...
6 September 2010 - by Gozde Zorlu 
Stem cell treatments offered by some private, international clinics need tighter regulation, an expert group of doctors, lawyers and bioethicists have warned. Vulnerable patients have spent thousands of pounds on unproven, expensive and risky treatments...
8 February 2010 - by Sarah Pritchard 
A research team at Stanford University School of Medicine has for the first time successfully transformed mouse skin cells directly into neurons. They achieved this by infecting the skin cells with a genetically modified virus that inserts three different genes into the cells' DNA...
23 August 2009 - by Alison Cranage 
The US Food and Drug Administration (FDA) has delayed the start of a clinical trial that plans to use human embryonic stem cell(ES) cells to treat spinal cord injury. The trial is being run by Californian based company Geron. The FDA originally gave the go-ahead for the trial in January, but now has halted the start in order to review new data submitted by Geron....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.